Congratulations to everyone from both labs on the exciting discovery that phosphoethanolamine, a metabolite not previously implicated in immunity, is enriched in tumors and suppresses T cell function and immunotherapy. Lot of exciting work to come to leverage this finding for new methods to improve immunotherapies. Check out the paper, the News and Views, and coverage from the UChicago Cancer Center.
new collaborative paper with delgoffe lab at Pitt on metabolites in the microenvironment of cancers that limit anti-tumor immunity
The Muir Lab 
Published by